Isaac Egesa | Medicine | Best Researcher Award

Published on by International Popular Scientist Awards

Best Researcher Award

Isaac Egesa
University of Liverpool, United Kingdom

Isaac Egesa
Affiliation University of Liverpool
Country United Kingdom
Scopus ID 57354615500
Documents 6
Citations 35
h-index 3
Subject Area Medicine
Event International Popular Scientist Awards
ORCID 0000-0003-0483-1517

Isaac Egesa is a researcher affiliated with the University of Liverpool whose reported scholarly work is situated within medicine and clinical research methodology. His recent publications and research protocols address patient and public involvement and engagement, sequential multiple-assignment randomized trials, target trial emulation, focal epilepsy, evidence synthesis, and methodological standards for clinical research. His Scopus profile records six indexed documents, 35 citations, and an h-index of 3. [1]

Abstract

Isaac Egesa’s recent research record reflects an emerging focus on clinical research methodology and evidence-based medicine. His work includes investigations of patient and public involvement and engagement in sequential multiple-assignment randomized trials and target trial emulation, as well as systematic evidence synthesis concerning antiseizure medication strategies for focal epilepsy. His publications span journal articles, research protocols, and conference outputs published or disseminated between 2025 and 2026. [2] [3] [4]

Keywords

Isaac Egesa; Best Researcher Award; Medicine; Clinical Research; Evidence-Based Medicine; Sequential Multiple-Assignment Randomized Trials; Target Trial Emulation; Patient and Public Involvement; Focal Epilepsy; Systematic Review; Clinical Epidemiology; Research Methodology.

Introduction

Contemporary clinical research increasingly requires methodological approaches capable of addressing complex treatment decisions, longitudinal evidence, patient perspectives, and the limitations of conventional randomized trial designs. Sequential multiple-assignment randomized trials (SMARTs) and target trial emulation are among the approaches used to investigate adaptive treatment strategies and strengthen the design or interpretation of observational and experimental evidence. Egesa’s recent work engages with these methodological areas while also considering the role of patients and the public in the development and conduct of clinical research. [5]

Research Profile

The available research information places Egesa within the medicine and clinical epidemiology research environment at the University of Liverpool. His listed Scopus record contains six documents, 35 citations, and an h-index of 3. [1] The publication record supplied for this profile demonstrates activity across several interconnected methodological themes rather than a single narrowly defined clinical topic.

Research Contributions

A principal component of Egesa’s recent work concerns patient and public involvement and engagement (PPIE). His research examines how PPIE is represented within sequential multiple-assignment randomized trials and target trial emulation frameworks. These studies address methodological questions concerning how patients and members of the public can participate in research processes involving complex trial structures. [2] [4]

Publications

The supplied publication record includes peer-reviewed journal articles, preprints, research protocols, and a conference poster. The following list summarizes the reported works in chronological order from 2025 through 2026.

  1. The extent of Patient and Public Involvement and Engagement in Sequential Multiple Assignment Randomised Trials: a scoping Review. Journal of Clinical Epidemiology, 2026.Contributors include Isaac J. Egesa, Faye D. Baldwin, Molly Wells, Gashirai Mbizvo, Richard Emsley, Laura J. Bonnett, Emily Lam, Andrew Kightley, Anthony G. Marson, and Catrin Tudur Smith.
  2. The extent of Patient and Public Involvement and Engagement in Sequential Multiple Assignment Randomised Trials: a scoping Review. Preprint, 2026. SSRN.
  3. The effectiveness of adding on or switching antiseizure medications after the first fails to control focal epilepsy: A systematic review of randomized controlled trials. Epileptic Disorders, 2026.
  4. Patient and public involvement and engagement in target trial emulation framework: a scoping review protocol. BMJ Open, 2026.

Research Impact

The significance of Egesa’s research can be considered in relation to methodological development in clinical and epidemiological research. His work addresses questions about how complex treatment strategies can be studied, how patient and public perspectives can be incorporated into research frameworks, and how methodological reporting can support interpretation and reproducibility. [2] [5]

Award Suitability

Based on the information supplied for this profile, Egesa’s research record provides a reasonable basis for consideration within a Best Researcher Award category. The record demonstrates recent scholarly activity, peer-reviewed publication, methodological research, protocol development, and participation in collaborative research involving multiple investigators. The available bibliometric indicators also provide measurable evidence of scholarly dissemination through indexed documents and citations. [1]

Conclusion

Isaac Egesa’s recent scholarly output reflects a developing research profile in medicine with a particular emphasis on clinical research methodology, patient and public involvement, adaptive trial designs, target trial emulation, and evidence synthesis. His 2025–2026 publications and protocols demonstrate engagement with contemporary methodological challenges and clinically relevant research questions.

References

  1. Elsevier. (n.d.). Scopus author details: Isaac Egesa, Author ID 57354615500. Scopus.
    https://www.scopus.com/pages/authors/57354615500
  2. Egesa, I. J., Baldwin, F. D., Wells, M., Mbizvo, G., Emsley, R., Bonnett, L. J., Lam, E., Kightley, A., Marson, A. G., & Tudur Smith, C. (2026). The extent of Patient and Public Involvement and Engagement in Sequential Multiple Assignment Randomised Trials: a scoping Review. Journal of Clinical Epidemiology.
    DOI: 10.1016/j.jclinepi.2026.112455
  3. Egesa, I. J., et al. (2026). The extent of Patient and Public Involvement and Engagement in Sequential Multiple Assignment Randomised Trials: a scoping Review. Preprint. SSRN.
    DOI: 10.2139/ssrn.6502250
  4. Egesa, I. J., Baldwin, F. D., Wells, M., Maden, M., Mbizvo, G. K., Marson, A. G., & Tudur-Smith, C. (2026). Patient and public involvement and engagement in target trial emulation framework: a scoping review protocol. BMJ Open.
    DOI: 10.1136/bmjopen-2025-113432
  5. Egesa, I. J., Bonnett, L., Emsley, R., Marson, A., & Smith, C. T. (2026). A review of use of external data and update on reporting standards in Sequential Multiple-Assignment Randomised Trials. Clinical Trials.
    DOI: 10.1177/17407745251385535

Laurence Klotz | Medicine | Best Researcher Award

Published on by International Popular Scientist Awards

Best Researcher Award

Laurence Klotz
University of Toronto
           Laurence Klotz
Affiliation University of Toronto
Country Canada
Scopus ID 55040556500
Documents 598
Citations 33,603
h-index 87
Subject Area Medicine
Event International Popular Scientist Awards

Laurence Klotz  the Best Researcher Award recognizes distinguished scholars whose sustained scientific contributions, publication record, scholarly influence, and leadership have significantly advanced their respective disciplines. Laurence Klotz of the University of Toronto is internationally recognized for his extensive contributions to medicine, particularly in the field of urology and prostate cancer research. His scholarly productivity, citation impact, and leadership in clinical research demonstrate the qualities commonly associated with internationally recognized academic excellence.[1]

Abstract

Laurence Klotz has established an internationally respected academic profile through decades of clinical investigation, scholarly publication, and leadership within medicine. His research has focused extensively on prostate cancer diagnosis, management, active surveillance, and evidence-based clinical practice. A substantial publication portfolio and strong citation performance demonstrate the widespread influence of his scientific work across medical research communities.[1]

Keywords

Best Researcher Award, Laurence Klotz, University of Toronto, Medicine, Urology, Prostate Cancer, Clinical Research, Active Surveillance, Medical Innovation, Scientific Publications.

Introduction

Recognition through a Best Researcher Award generally reflects sustained scholarly productivity, innovation, research quality, international visibility, and measurable scientific impact. Laurence Klotz has contributed extensively to advancing evidence-based medicine through clinical investigations and peer-reviewed publications that have influenced patient management strategies and international clinical discussions.[2]

Research Profile

  • Institution: University of Toronto
  • Country: Canada
  • Primary Discipline: Medicine
  • Scopus Author ID: 55040556500
  • Indexed Documents: 598
  • Citation Count: 33,603
  • h-index: 87

Research Contributions

The research contributions of Laurence Klotz encompass clinical trials, translational medicine, evidence-based treatment strategies, and innovations in prostate cancer management. His investigations have supported advances in active surveillance protocols, patient risk stratification, biomarker evaluation, and improvements in clinical decision-making. These studies have contributed to contemporary understanding of disease progression while supporting safer and more personalized treatment pathways.[2]

Publications

  • Over 598 indexed scholarly publications in Scopus.
  • Research published in internationally recognized peer-reviewed medical journals.
  • Representative publication includes research related to active surveillance for prostate cancer.

Research Impact

A citation count exceeding thirty-three thousand together with an h-index of eighty-seven reflects broad scholarly recognition and sustained influence within the medical research community. Such bibliometric indicators demonstrate that published findings have been consistently referenced by researchers, clinicians, and guideline developers internationally.[1]

Award Suitability

Based on publicly available scholarly metrics and research accomplishments, Laurence Klotz demonstrates many characteristics commonly considered during evaluations for international academic recognition programs. These include sustained publication productivity, high citation impact, influential clinical research, interdisciplinary collaboration, scientific leadership, and measurable contributions to medical knowledge. Award decisions remain dependent upon the formal evaluation criteria established by the organizing committee of the International Popular Scientist Awards.[3]

Conclusion

Laurence Klotz has developed a distinguished international academic profile characterized by extensive publication activity, strong citation performance, and influential contributions to medicine. His research achievements, leadership within clinical science, and continued scholarly engagement illustrate the qualities frequently associated with internationally recognized research excellence and provide an informative example of academic achievement within the context of the Best Researcher Award.

References

  1. Elsevier. (n.d.). Scopus author details: Laurence Klotz, Author ID 55040556500. Scopus.
    https://www.scopus.com/pages/authors/55040556500
  2. Klotz, L. (2010). Active surveillance for favorable-risk prostate cancer. Journal of Clinical Oncology.
    DOI: https://doi.org/10.1200/JCO.2010.31.6951
  3. International Popular Scientist Awards. (n.d.). Award information and nomination guidelines.
    https://popularscientist.com/
  4. Kasivisvanathan, V., Rannikko, A. S., Borghi, M., Panebianco, V., Mynderse, L. A., Vaarala, M. H., Briganti, A., Budäus, L., Hellawell, G., Hindley, R. G., Roobol, M. J., Eggener, S., Gnanapragasam, V. J., Klotz, L., Taneja, S. S., George, A. K., Catalona, W. J., Hadaschik, B. A., Marks, L. S., … Emberton, M. (2018). MRI-targeted or standard biopsy for prostate-cancer diagnosis.